Lake Street Maintains Buy on Envoy Medical, Raises Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen has maintained a Buy rating on Envoy Medical (NASDAQ:COCH) and increased the price target from $3 to $6.

April 03, 2024 | 1:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lake Street analyst Frank Takkinen has reaffirmed a Buy rating on Envoy Medical and raised the price target from $3 to $6.
The increase in price target from $3 to $6 by a reputable analyst suggests a strong bullish outlook on Envoy Medical's stock. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price, as market participants often react positively to analyst upgrades and higher price targets.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100